Call for Abstract

Cancer Genomics Conference: New Era for Cancer Prevention , will be organized around the theme “Exploring ways to use genomics data to reveal new targets and therapies”

Cancer Genomics 2018 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Cancer Genomics 2018

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

Oncogenomics also called Cancer genomics is one among the sub-field of genomics that characterizes cancer-associated genes. Cancer is a hereditary disease caused by accumulation of DNA mutations and epigenetic changes leading to unrestricted cell proliferation and neoplasm formation. It emphases on genomic, epigenomic and transcript alterations in cancer. The cancer genomics has a goal to identify new oncogenes or tumor suppressor genes that may offer new insights into cancer diagnosis, predicting clinical outcome of cancers and new targets for cancer therapies. The success of targeted cancer therapies such as Gleevec, Herceptin and Avastin elevated the hope for oncogenomics to elucidate new targets for cancer treatment. 

  • Track 1-1Genomic modifications
  • Track 1-2Innovative advances in cancer
  • Track 1-3Cancer Pharmacogenomics
  • Track 1-4Oncogenomics
  • Track 1-5Next generation sequencing technologies
  • Track 1-6Genomic characterization pipeline
  • Track 1-7Molecular and Genomic signature
  • Track 1-8Oncogenes

Cancer is characterized by uncontrolled cell growth, which is spread to different body parts, that leads to formation of lumps or masses of tissue called tumours. One among the leading causes of death all over the world is Cancer. Based on the location of cancer in the body organ, the Organ Specific Cancers are named. There are different kinds of cancers which effects  different body organs. Some of them are   Brain cancer, Head and Neck Cancer, Breast cancer, Prostate cancer, Lung cancer, Oral cancer, Liver cancer, Gastric cancer, Pancreatic cancer, Kidney (Renal Cell) cancer, Leukemia and many more. 

  • Track 2-1Dermatological carcinoma
  • Track 2-2Pulmonary and renal carcinoma
  • Track 2-3Thyroid and hepatic carcinoma
  • Track 2-4Prostate cancer
  • Track 2-5Gynecology and Obstetrics
  • Track 2-6Breast cancer metastasis and xenograft
  • Track 2-7Dynamics and genomics of pancreatic cancer
  • Track 2-8Malignant Fibrous Histiocytoma of Bone and Osteosarcoma
  • Track 2-9Urology cancer symptoms

The cancer that grows from breast tissue is called as Breast cancer.  Signs of breast cancer may comprise a lump in the breast, dimpling of the skin, fluid coming from the nipple, an alteration in breast shape,  or a red scaly patch of skin. In those with distant spread of the disease, there may be swollen lymph nodes, bone pain, shortness of breath, or yellow skin. Risk factors comprises being female,  lack of physical exercise, obesity, hormone replacement therapy during menopause, drinking alcohol,  ionizing radiation, early age at first menstruation, older age,  having children late or not at all, and family history. Counting BRCA1 and BRCA2 among others, about 5–10% of cases are due to genes inherited from a person's parents. 

  • Track 3-1Breast cancer screening
  • Track 3-2Breast reconstruction
  • Track 3-3Lobular carcinoma
  • Track 3-4Breast MRI
  • Track 3-5Breast Cancer- Present Perspective
  • Track 3-6Surgery Choices for Breast Cancer
  • Track 3-7Breast Cancer Therapy, Prevention and Medicine
  • Track 3-8Breast Cancer-Clinical Trials
  • Track 3-9Screening, Detecting and Diagnosing Breast Cancer

Gynecologic Oncology also called Cervical Cancer and it is one of the most common cancers in women worldwide. This cancer is not so common in the United States and other countries where cervical cancer screening is repetitive. Cervical cancer is mostly caused due to a virus called Human papillomavirus or also predicted as HPV. There are numerous kinds of the HPV virus, but all of HPV does not reason cervical cancer. Certain of them cause genital warts, but other types may not display any Cervical Cancer signs and symptoms . An infection can go away on its own. But occasionally it can cause genital warts or can also central to cervical cancer, it's significant for women to have regular Pap tests

  • Track 4-1Cervical malignancy
  • Track 4-2Female conceptive organs
  • Track 4-3Endometrial /uterine cancer
  • Track 4-4Gynecologic Surgery
  • Track 4-5Gynecologic Cancer: Treatment and Monitoring
  • Track 4-6Ablative Technologies in Gynecology
  • Track 4-7New Technologies in Reproductive Cancer
  • Track 4-8Gynecologic Cancer Prevention and Control
  • Track 4-9Gynecologic Oncology: Pathogenesis

Pediatric cancer is also called as Childhood cancer which is cancer in a child. In the United States, an subjectively adopted standard of the ages used are 0–14 years wide-ranging, that is, up to 14 years 11.9 months of age. However, in some cases the meaning of childhood cancer comprises adolescents between 15–19 years old. Pediatric oncology is the branch of medicine concerned with the diagnosis and cure of cancer in children. In the Universe, it is assessed that pediatric cancer has an incidence of more than 175,000 per year, and a mortality rate of approximately 96,000 per year. In the urbanized countries, pediatric cancer has a mortality rate of nearly 20% of cases. In low resource settings, on the other hand, mortality is nearly 80%, or even 90% in the world's poorest countries.  

  • Track 5-1Pleuropulmonary blastoma
  • Track 5-2Myeloid leukemias
  • Track 5-3Hepatoblastoma
  • Track 5-4Pediatric radiology
  • Track 5-5Nursing care in pediatric cancer
  • Track 5-6Clinical pediatrics
  • Track 5-7Pediatric neuroblastoma
  • Track 5-8Retinoblastoma
  • Track 5-9Germ cell tumor
  • Track 5-10Pediatric Hematology Oncology

brain tumor occurs when unusual cells form within the brain. Malignant or cancerous tumors and benign tumors are the two main types of tumors. Cancerous tumors can be distributed into primary tumors which starts within the brain, and the secondary tumors which are spread from anywhere else, identified as brain metastasis tumors. All sorts of brain tumors may produce symptoms that differ depending on the brain part involved. These symptoms may comprise problem with vision, vomiting, headaches, seizures, and mental changes. The headache is characteristically worse in the morning and drives away with vomiting. More particular problems may include difficulty in walking, speaking, and with sensation. As the disease advances unconsciousness may occur. 

  • Track 6-1Brain metastasis
  • Track 6-2Glioblastoma multiforme
  • Track 6-3Medical Treatment of Metastatic Cancer to the Nervous System
  • Track 6-4Neuro-Pharmacology and Neuro-Toxicology
  • Track 6-5Neuroblastoma oncogenomics
  • Track 6-6Para Neoplastic Neurological Syndrome
  • Track 6-7Novel Therapies in Neuro-Oncology

Hematologic Oncology is the branch of medicine deals with the diagnosis, prevention, treatment of disease identified with blood. Hematology includes the study of etiologist comprises the treatment of disease that influence the construction of blood and its parts, for example, platelets, hemoglobin, blood proteins, bone marrow, platelets, veins, spleen, and the component of coagulation. The research facility work that goes into the study of blood is much of the time done by a medical technologist or therapeutic lab researcher. There are different disorders that people are influenced by hematology. The different type of blood conditions that are looked at incorporate anemia, hemophilia, general blood clots, bleeding disorders With reverence to related blood diseases, for example, leukemia, myeloma, and lymphoma, these are more serious cases that should be analyzed.

  • Track 7-1Chronic lymphocytic leukemia
  • Track 7-2Hematological malignancies
  • Track 7-3Plasma cell disorders
  • Track 7-4Myelodysplastic syndrome
  • Track 7-5Anemia & Bleeding Disorders
  • Track 7-6Hematologic Malignancies: Prognosis
  • Track 7-7Advances in Bone Marrow Transplantation and Surgery

An antibody that either treats existing malignancy or averts improvement of a growth is called tumor immunization which accounts cancer immunology.  The third and last stage in tumor development is Tumor progression. By expanded development speed and invasiveness of the tumor cells, this stage is arranged. It was investigated by Obeid et al. how inducing immunogenic cancer cell death ought to become a priority of cancer chemotherapy.

He gave a reason that, via a ‘bystander effect’, the immune system would be able to play a factor in destroying chemotherapy-resistant cancer cells. However, the depth in the research is still necessary on how the immune response is triggered against dying tumour cells. 

  • Track 8-1Proteins as antigens
  • Track 8-2Tumor progression
  • Track 8-3Antigen processing and presentation
  • Track 8-4Novel Approaches in Cancer & Tumor
  • Track 8-5Targeting Immunotherapy Cancer Treatment
  • Track 8-6Immune system Stimulants
  • Track 8-7Newer Monoclonal Antibodies
  • Track 8-8Eco-immunology, Behavioral Immunity and Molecular Immunology

Radiation oncology is the medical field concerned with prescribing radiation, and is separate from radiology. Radiation oncology is the use of radiation in medical imaging and diagnosis. Radiation may be recommended by a radiation oncologist with intent to cure ("curative") or for adjuvant therapy. It may also be used as therapeutic treatment (where the therapy has survival benefit and it can be curative) or palliative treatment (where cure is not possible and the aim is for local disease control or symptomatic relief) . It is also mutual to combine radiation therapy with chemotherapy, surgery, hormone therapy,  or some mixture of the four. Radiation therapy treats most common cancer types in some way. Radiation therapy also called Radiotherapy, commonly abbreviated RTRTx, or XRT, is therapy using ionizing radiation, generally as portion of cancer treatment to control or kill malignant cells and normally delivered by a linear accelerator. 

  • Track 9-1Stem cell therapy
  • Track 9-2Radiology: Mammography
  • Track 9-3Radiology: Sonography
  • Track 9-4Radiology: Computed Tomography
  • Track 9-5Radiology: Nuclear Magnetic Resonance Imaging
  • Track 9-6Stereotactic body radiation therapy (sbrt)
  • Track 9-7Radiosensitizers and radioprotectors
  • Track 9-8Brachytherapy (sealed source radiotherapy)
  • Track 9-9Medical and radiation physics
  • Track 9-10Recent Advances in Radiation Therapy

Clinical Oncology comprises Medical Oncology (MO)Surgical Oncology (SO)Gynecologic Oncology, Hematologic Malignancies. Medical oncology interconnects the results of clinical and experimental study in oncology and haematology, mainly with experimental therapeutics with the field of immunotherapy and chemotherapy. A surgical and non-surgical oncologist specializes in the elimination of the tumours and nearby tissue during an operation. Hematologic malignancies are forms of cancer that begin in the cells of blood-forming tissue, such as the bone marrow, or in the cells of the immune system. Thus clinical oncology and Cancer Stem Cell is a unique therapeutic approach.

  • Track 10-1Surgical and non-surgical oncology
  • Track 10-2Cancer Diagnostics
  • Track 10-3Clinical and Translational Immunology
  • Track 10-4Analytical Techniques in Pharmacogenomics
  • Track 10-5Cancer Causing and Cancer fighting foods
  • Track 10-6Genomic and Clinical data sets

The study of the factors affecting cancer is called as epidemiology of cancer, as a way to infer possible trends and causes. The study of cancer epidemiology uses epidemiological methods in certain population to find what are the cancer  causes and to identify in order to develop improved treatments. Basing on the progress of the disease, Cancer epidemiology is principally concerned with the study of cancer, its causes, detection, and treatment. 7.98 million people died in the year 2010 due to Cancer and Approximately 12.7 million cancers were diagnosed every year.  

Increase in the age increases the high risk of cancer. The common childhood cancers are lymphomas around 14%, leukemia around 34%, and brain tumors around 23%. Cancer epidemiology study must contend with problems of  lead time bias and length time bias.  

  • Track 11-1Tumor transmission
  • Track 11-2Environmentally Induced Malignancies
  • Track 11-3Critical Hazards of Cancer
  • Track 11-4Incidence and Mortality
  • Track 11-5Observational epidemiological studies
  • Track 11-6Randomized controlled trials

The appearance of signs or symptoms or through screening, the cancers are initially predictable. Neither of these indications to a definitive diagnosis, which entails the examination of a tissue sample by a pathologist. Medical tests are done to reveal the investigations in People with suspected cancer. These commonly include  X-rays, CT scans, blood tests, and endoscopy.

The tissue diagnosis from the biopsy indicates the type of cell that is proliferating, genetic abnormalities, its histological grade, and other features. Together, this information is useful to assess the prognosis and to pick the best treatment. 

  • Track 12-1Health history review
  • Track 12-2Cancer and Alternative Medicine
  • Track 12-3Cancer : Vaccines and Prevention
  • Track 12-4Clinical Cancer research
  • Track 12-5Cancer Diagnostics Market
  • Track 12-6Advances in Cancer treatment and therapy

Biomarkers are limited to measurement of  proteins in the blood or urine. Biomarkers refers to a substance or process that indicates the presence of cancer in the body. There are different  biomarkers used for the prognosis, diagnosis and epidemiology like epigenetic, Genetic,   glycomics, proteomic, and imaging biomarkers. A number of gene and protein based biomarkers have already been used at some point in patient care; including:

·         PSA (Prostate Specific Antigen) (Prostate Cancer),

·         AFP (Liver Cancer), 

·         BRCA1 / BRCA2 (Breast/Ovarian Cancer), 

·         BRAF V600E (Melanoma/Colorectal Cancer), 

·         CA-125 (Ovarian Cancer), BCR-ABL (Chronic Myeloid Leukemia),  

  • Track 13-1Protein biomarkers
  • Track 13-2Fluorescent biomarkers
  • Track 13-3Cancer Risk evaluation
  • Track 13-4Cancer epidemiology biomarkers
  • Track 13-5Prognosis and treatment
  • Track 13-6Biomarkers in Cancer Research

Cancer stem cells (CSCs) is the cancer cells found inside tumors  that possess characteristics associated with normal stem cells called which have the capability to give growth to all cell types found in a particular cancer sample. CSCs may generate tumors through the stem cell processes of self-renewal and variation into multiple cell types. Such cells are hypothesized to persevere in tumors as a distinct population and cause relapse and metastasis by giving rise to new tumors. Therefore, for improvement of survival and quality of life of cancer patients,  development of specific therapies targeted at CSCs holds hope, particularly for patients with metastatic disease. Mostly based on animal models Existing cancer treatments have been advanced, where therapies able to endorse tumor shrinkage were deemed effective. 

  • Track 14-1LASER and LASIC
  • Track 14-2Technologies in Stem Cell Research
  • Track 14-3Cell & Gene Therapy Development & Production
  • Track 14-4Bio Materials and Tissue Engineering
  • Track 14-5Tissue Preservation and Bio Banking
  • Track 14-6Induced Pluripotent Stem Cells
  • Track 14-7Bone marrow Transplantation
  • Track 14-8Angiogenesis Inhibitors
  • Track 14-9Stem cell transplantation
  • Track 14-10Malignant and non-malignant diseases
  • Track 14-11Cellular and Technological Breakthroughs in Cancer

To quantify distress in men treated with radical prostatectomy (RP) or active surveillance (AS). Methods: In a retrospective cross-sectional design, we assessed men through questionnaire and investigator-designed questions. Results: RP patients worried more about cancer spread than AS patients. RP patients were influenced by friends for treatment decision, whereas AS patients were influenced by urologists. RP group report declines in intimacy and instrumental. AS men worried more about future health and dying than post-RP men. Conclusion: Fear of disease progression may be a motivating factor in choosing RP. AS patients adhere to their treatment decision in spite of distress.

 

Drug collaboration in oncology is of specific importance attributable to the tight healing list and the unchallengeable lethality of anticancer specialists. Besides treating cancer, it is also necessary to  relieve symptoms of the cancer such as pain and side-effects, such as nausea, commonly seen with the several types of treatment. Some of the anticancer drugs are Cabazitaxel, Cetuximab, etc... Chemotherapy drug combinations are as such Cisplatin, Crizotinib.

Surgery applied to oncology is called Surgical oncology, applied to oncology which includes the surgical management of tumours, mainly cancerous tumours. There are other names of Surgical oncologist as general surgical oncologist, thoracic surgical oncologists, subspecialty of general surgery, gynecologic oncologists experienced  in handling  the cancer patients.

  • Track 16-1Advances in development of Anti-cancer drugs and Alkylating agents
  • Track 16-2Cytotoxic and Targeted Therapies
  • Track 16-3Treatment strategies of cancer
  • Track 16-4Gastrectomy
  • Track 16-5Surgical oncologist
  • Track 16-6Surgery
  • Track 16-7Chemotherapy
  • Track 16-8Nanotechnology in cancer drugs
  • Track 16-9Chemotherapeutic agents
  • Track 16-10Antineoplastic drug

Cancer pharmacology referred as Chemotherapy (frequently abbreviated to chemo and sometimes CTX or  CTx) is a class of cancer treatment. Chemotherapy uses one or more anti-cancer drugs (chemotherapeutic agents) as portion of a consistent chemotherapy regimen. In the cancer pharmacology combination of drugs are used to extend life or to decrease symptoms which is palliative chemotherapy. Chemotherapy is one of the major groups of the medical discipline specifically devoted to pharmacotherapy for cancer, which is named medical oncology. To avoid these implications, recently developed treatments (against specific molecular or genetic targets) which constrain growth-promoting signals coming from classic endocrine hormones like primarily estrogens for breast cancer and androgens for prostate cancer, are named hormonal therapies, whereas the reticence of other growth-promoting influences is called as targeted therapy.

  • Track 17-1Cell replication
  • Track 17-2Apoptosis
  • Track 17-3Nanotechnology and Nanomedicine
  • Track 17-4Cancer pharmacodynamics and pharmacokinetics
  • Track 17-5Therapeutic antibodies
  • Track 17-6Novel drug delivery system
  • Track 17-7Cancer drug designing
  • Track 17-8Malignant transformation
  • Track 17-9Cancer cell proliferation

Cancer screening targets to detect cancer before symptoms appear. This may involve urine tests, blood tests,  other tests, or medical imaging. Early detection and subsequent treatment must be considered against any troubles, which are benefits of screening in terms of cancer prevention, The Universal screening, is also known as mass screening or population screening, which includes screening everyone, usually within a specific age group. People with a family history of cancer are known to be at higher risk of developing cancer are identified as Selective screening. 

  • Track 18-1Screening
  • Track 18-2Carcinogens
  • Track 18-3Chronic inflammations
  • Track 18-4Colonoscopy
  • Track 18-5Mammography
  • Track 18-6Nuclear imaging
  • Track 18-7Novel therapeutic approaches
  • Track 18-8Chemoprevention

An oncology nurse is a specified nurse who cares for the cancer patients. These nurses require progressive certifications and clinical skills in oncology additional than the typical bachelorette nursing program provides. Oncology nursing care can be defined as meeting the various needs of oncology patients during the period of their disease counting appropriate screenings and other preventative practices, symptom management, care to hold as much normal functioning as possible, and supportive measures upon end of life. Nurses must be able to manage the numerous side effects related with cancer and the treatment. Nurses must have widespread knowledge of pharmacological and non-pharmacological nursing intrusions, and when they are appropriate to use.  

  • Track 19-1Clinical implications
  • Track 19-2Palliative care
  • Track 19-3Marrow transplant unit
  • Track 19-4Inpatient and outpatient wards
  • Track 19-5Cancer care and psychological help
  • Track 19-6Anticipatory greeving nursing care plan
  • Track 19-7Risk for fluid volume deficit
  • Track 19-8Preventive oncology

The information of the preventive or therapeutic interventions is given by the case reports of oncology and Cancer Stem Cell , as these generally require stronger evidence. Thus a case report is an enlarged report of all the particulars of a disease or of a disorder usually made for an individual patient regularly logged in the medical field. The demographic profile of the patient suffering from disease is given by case reports, but stereotypically reference any unusual or unique occurrences. In this Cancer based conference, various special cases where treatment was undiscovered or a special case which might lead the understandings into the Oncology research are discussed. 

  • Track 21-1Clinical case reports
  • Track 21-2Clinical oncologists
  • Track 21-3Cancer diagnostics
  • Track 21-4Clinical trails
  • Track 21-5Medical oncology
  • Track 21-6Oncology research
  • Track 21-7Cancer stem cell
  • Track 21-8Non-surgical oncology